FIRST DIAGNOSIS OF UVEITIS IS NOT HIGHER AMONG JUVENILE IDIOPATHIC ARTHRITIS (JIA) PATIENTS RECEIVING ETANERCEPT COMPARED TO METHOTREXATE

被引：0
|
作者：
Davies, R. [1 ]
De Cock, D. [1 ]
Kearsley-Fleet, L. [1 ]
Ramanan, A. [2 ,3 ]
Hyrich, K. L. [1 ,4 ]
机构：
[1] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Ctr Epidemiol, Manchester, Lancs, England
[2] Univ Hosp Bristol NHS Fdn Trust, Pediat Rheumatol, Bristol, Avon, England
[3] Univ Bristol, Sch Clin Sci, Ophthalmol, Bristol, Avon, England
[4] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Natl Inst Hlth Res Manchester Musculoskeletal Bio, Manchester, Lancs, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.5211
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0351
引用
收藏
页码：221 / 222
页数：2
相关论文
共 50 条
  • [21] Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
    MG Alpigiani
    A Calcagno
    R De Marco
    M Haupt
    P Salvati
    E Poggi
    R Lorini
    Pediatric Rheumatology, 6 (Suppl 1)
  • [22] Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
    C Bracaglia
    PS Buonuomo
    S Caminiti
    A Insalaco
    A Campana
    E Cortis
    Pediatric Rheumatology, 6 (Suppl 1)
  • [23] Treatment Options for Juvenile Idiopathic Arthritis (JIA) Associated Uveitis
    Amin, Rowayda M.
    Miserocchi, Elisabetta
    Thorne, Jennifer E.
    Hornbeak, Dana
    Jabs, Douglas A.
    Zierhut, Manfred
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2016, 24 (01) : 81 - 90
  • [24] Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis (JIA) patients
    South-Wood, Taunton
    Cummins, Carole
    Cotter, Catherine
    Rahman, Joy
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S943 - S944
  • [25] TREATMENT WITH LEFLUNOMIDE RESULTS IN A HIGHER FLARE RATE OF CHRONIC UVEITIS COMPARED TO METHOTREXATE IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH BOTH DRUGS
    Bichler, J.
    Krumrey-Langkammerer, M.
    Haas, J. -P.
    Hugle, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 734 - 734
  • [26] Adverse events in juvenile idiopathic arthritis patients treated with etanercept or the combination of etanercept and methotrexate.
    Southwood, TR
    Cummins, CL
    Foster, HE
    Rahman, JK
    Cotter, KB
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S85 - S86
  • [27] Methotrexate (MTX) Toxicity Surveillance in Juvenile Idiopathic Arthritis (JIA)
    Kocharla, Lakshmi P.
    Taylor, Janalee
    Weiler, Tracy
    Luggen, Michael
    Brunner, Hermine
    ARTHRITIS AND RHEUMATISM, 2008, 58 (12): : 3986 - 3986
  • [28] Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis
    Ramanan, Athimalaipet V.
    Dick, Andrew D.
    Jones, Ashley P.
    McKay, Andrew
    Williamson, Paula R.
    Compeyrot-Lacassagne, Sandrine
    Hardwick, Ben
    Hickey, Helen
    Hughes, Dyfrig
    Woo, Patricia
    Benton, Diana
    Edelsten, Clive
    Beresford, Michael W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (17): : 1637 - 1646
  • [29] Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis
    Ruchalla, Elke
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2017, 234 (10)
  • [30] An in-depth analysis of young people's experience of their juvenile idiopathic arthritis (JIA) once receiving Etanercept
    P Livermore
    P Woo
    LR Wedderburn
    Pediatric Rheumatology, 6 (Suppl 1)
12345